Baker Brothers Advisors - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 89 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,536,253
+55.3%
3,410,1060.0%0.01%
+80.0%
Q1 2023$988,931
-35.5%
3,410,1060.0%0.01%
-44.4%
Q4 2022$1,534,207
-14.5%
3,410,1060.0%0.01%
-25.0%
Q3 2022$1,794,000
+4.2%
3,410,1060.0%0.01%
+20.0%
Q2 2022$1,722,000
-78.0%
3,410,1060.0%0.01%
-77.8%
Q1 2022$7,843,000
-51.6%
3,410,1060.0%0.04%
-43.0%
Q4 2021$16,198,000
-40.3%
3,410,1060.0%0.08%
-33.6%
Q3 2021$27,110,000
+14.2%
3,410,1060.0%0.12%
+14.4%
Q2 2021$23,734,000
-12.1%
3,410,1060.0%0.10%
-11.1%
Q1 2021$27,008,000
+0.6%
3,410,1060.0%0.12%
+15.8%
Q4 2020$26,838,000
-13.6%
3,410,106
-22.1%
0.10%
-18.5%
Q3 2020$31,051,000
-23.4%
4,379,5920.0%0.12%
-30.7%
Q2 2020$40,511,000
+407.3%
4,379,592
+155.6%
0.18%
+265.3%
Q1 2020$7,985,000
-39.0%
1,713,6040.0%0.05%
-30.0%
Q4 2019$13,092,000
-0.7%
1,713,6040.0%0.07%
-22.2%
Q3 2019$13,178,000
+12.3%
1,713,6040.0%0.09%
+12.5%
Q2 2019$11,738,000
-14.9%
1,713,6040.0%0.08%
-9.1%
Q1 2019$13,795,000
+7.5%
1,713,6040.0%0.09%
-16.2%
Q4 2018$12,835,000
-3.4%
1,713,604
+23.5%
0.10%
+20.7%
Q3 2018$13,282,000
-9.5%
1,387,8720.0%0.09%
-20.9%
Q2 2018$14,684,000
+30.1%
1,387,872
+22.0%
0.11%
+14.6%
Q1 2018$11,288,000
+83.4%
1,137,8720.0%0.10%
+81.1%
Q4 2017$6,156,000
+9.8%
1,137,8720.0%0.05%
+17.8%
Q3 2017$5,609,000
+28.0%
1,137,8720.0%0.04%
+18.4%
Q2 2017$4,381,000
+209.6%
1,137,872
+498.9%
0.04%
+216.7%
Q1 2017$1,415,000
-19.5%
189,987
-53.0%
0.01%
-29.4%
Q4 2016$1,758,000
-32.1%
404,2300.0%0.02%
-29.2%
Q3 2016$2,591,000
+31.9%
404,2300.0%0.02%
+14.3%
Q2 2016$1,965,000404,2300.02%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Yu Fan 112,044$258,0003.49%
Aisling Capital Management LP 1,691,151$3,890,0002.10%
Sio Capital Management, LLC 871,101$2,004,0000.66%
Bain Capital Life Sciences Investors, LLC 2,847,689$6,550,0000.64%
Samsara BioCapital, LLC 883,720$2,033,0000.51%
Ghost Tree Capital, LLC 686,599$1,579,0000.34%
Nantahala Capital Management 3,200,593$7,361,0000.33%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO 245,678$565,0000.29%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,059,894$9,338,0000.28%
Lion Point Capital, LP 300,000$690,0000.16%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders